Cargando…

Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743615/ https://www.ncbi.nlm.nih.gov/pubmed/35023901 http://dx.doi.org/10.2147/DDDT.S355100

Ejemplares similares

Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer
por: Liu, Ying, et al.
Publicado: (2020)

Stratification of Tamoxifen Synergistic Combinations for the Treatment of ER+ Breast Cancer
por: Zboril, Emily K., et al.
Publicado: (2023)

Fatostatin induces pro- and anti-apoptotic lipid accumulation in breast cancer
por: Brovkovych, Viktor, et al.
Publicado: (2018)

Uracil-tegafur and tamoxifen versus cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in postoperative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study
por: Park, Y, et al.
Publicado: (2009)

Corrigendum to: Modification of ERα by UFM1 Increases Its Stability and Transactivity for Breast Cancer Development
por: Yoo, Hee Min, et al.
Publicado: (2023)

Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer
por: Ye, Liping, et al.
Publicado: (2022)

Fatostatin ameliorates inflammation without affecting cell viability
por: Ma, Shuhe, et al.
Publicado: (2022)

The combination of methylsulfonylmethane and tamoxifen inhibits the Jak2/STAT5b pathway and synergistically inhibits tumor growth and metastasis in ER-positive breast cancer xenografts
por: SP, Nipin, et al.
Publicado: (2015)

Quantification of Synergistic Effects of Ceragenin CSA-131 Combined with Iron Oxide Magnetic Nanoparticles Against Cancer Cells [Corrigendum]
Publicado: (2023)

Corrigendum to “Synergistic Effects of Toxic Elements on Heat Shock Proteins”
por: Mahmood, Khalid, et al.
Publicado: (2015)

Fatostatin induces ferroptosis through inhibition of the AKT/mTORC1/GPX4 signaling pathway in glioblastoma
por: Cai, Jiayang, et al.
Publicado: (2023)

Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer
por: Tsoi, Ho, et al.
Publicado: (2022)

Synergistic Effect Of A Retinoid X Receptor-Selective Ligand Bexarotene And Docetaxel In Prostate Cancer [Corrigendum]
Publicado: (2019)

[Corrigendum] Mesenchymal stem cells expressing interleukin‑18 inhibit breast cancer in a mouse model
por: Liu, Xiaoyi, et al.
Publicado: (2023)

Metformin enhances tamoxifen-mediated tumor growth inhibition in ER-positive breast carcinoma
por: Ma, Ji, et al.
Publicado: (2014)

Fulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ERα positive breast cancer by up-regulation of ERβ
por: Mishra, Ameet K., et al.
Publicado: (2016)

Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-κB pathway in endometrial carcinoma
por: Ma, Xiaohong, et al.
Publicado: (2021)

Taxanes in the elderly patient with metastatic breast cancer [Corrigendum]
Publicado: (2019)

PLK1 as a potential prognostic marker of gastric cancer through MEK-ER K pathway on PDTX models [Corrigendum]
Publicado: (2019)

Tamoxifen Action in ER-Negative Breast Cancer
por: Manna, Subrata, et al.
Publicado: (2016)

Corrigendum to “Detarium microcarpum, Guiera senegalensis, and Cassia siamea Induce Apoptosis and Cell Cycle Arrest and Inhibit Metastasis on MCF7 Breast Cancer Cells”
por: Adebayo, Ismail Abiola, et al.
Publicado: (2019)

Huaier extract synergizes with tamoxifen to induce autophagy and apoptosis in ER-positive breast cancer cells
por: Qi, Wenwen, et al.
Publicado: (2016)

Construction of High Loading Natural Active Substances Nanoplatform and Application in Synergistic Tumor Therapy [Corrigendum]
Publicado: (2022)

Corrigendum to “Synergistic Effect of MiR-146a Mimic and Cetuximab on Hepatocellular Carcinoma Cells”
por: Huang, Suning, et al.
Publicado: (2020)

Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer [Corrigendum]
Publicado: (2014)

Targeting PIK3CG in Combination with Paclitaxel as a Potential Therapeutic Regimen in Claudin-Low Breast Cancer [Corrigendum]
Publicado: (2020)

Corrigendum to: EGFR mediates LPA‐induced proteolytic enzyme expression and ovarian cancer invasion: Inhibition by resveratrol
Publicado: (2019)

Corrigendum to “Recent Advances in Microwave Imaging for Breast Cancer Detection”
por: Kwon, Sollip, et al.
Publicado: (2018)

Corrigendum to “Autophagy Inhibition Enhances Apoptosis Induced by Dioscin in Huh7 Cells”
por: Hsieh, Ming-Ju, et al.
Publicado: (2017)

Cell penetrating peptide-modified nanoparticles for tumor targeted imaging and synergistic effect of sonodynamic/HIFU therapy [Corrigendum]
Publicado: (2019)

The role of taxanes in triple-negative breast cancer: literature review [Corrigendum]
Publicado: (2015)

Phototherapy Using Er,Cr:YSGG Laser as a Definitive Treatment for Dentin Hypersensitivity: A Systematic Review [Corrigendum]
Publicado: (2022)

Phototherapy Using Er,Cr:YSGG Laser as a Definitive Treatment for Dentin Hypersensitivity: A Systematic Review [Corrigendum]
Publicado: (2022)

Hyperactivation of MAPK Induces Tamoxifen Resistance in SPRED2-Deficient ERα-Positive Breast Cancer
por: Vafeiadou, Vasiliki, et al.
Publicado: (2022)

Corrigendum to “Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients”
por: Qian, Lei, et al.
Publicado: (2022)

Combined Photodynamic and Photothermal Therapy and Immunotherapy for Cancer Treatment: A Review [Corrigendum]
Publicado: (2023)

Chrysin Induced Cell Apoptosis and Inhibited Invasion Through Regulation of TET1 Expression in Gastric Cancer Cells [Corrigendum]
Publicado: (2021)

Cooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia [Corrigendum]
Publicado: (2018)

Corrigendum to “A Randomized Controlled Trial of Chinese Patent Medicine Xiao'er Biantong Granules in the Treatment of Functional Constipation in Children”
por: Cai, Qiu-han, et al.
Publicado: (2018)

Corrigendum to “Determine the Role of FSH Receptor Binding Inhibitor in Regulating Ovarian Follicles Development and Expression of FSHR and ERα in Mice”
por: Lai, Luju, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m1cnmcleli0setseh5mranpfk3